Decitabine and Piperacillin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Decitabine (decitabine) and Piperacillin (piperacillin sodium). Common drug interactions include mouth ulceration among females and dysuria among males.

The phase IV clinical study analyzes what interactions people have when they take Decitabine and Piperacillin. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Decitabine?

Decitabine has active ingredients of decitabine. eHealthMe is studying from 4,605 Decitabine users. Check the latest studies of Decitabine.

What is Piperacillin?

Piperacillin has active ingredients of piperacillin sodium. eHealthMe is studying from 5,597 Piperacillin users. Check the latest studies of Piperacillin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

21 people who take Decitabine and Piperacillin together, and have interactions are studied.

Decitabine and Piperacillin drug interactions.

What are the common drug interactions of Decitabine and Piperacillin, by gender? *:

female:

  1. Mouth ulceration (mouth ulcers)
  2. Myalgia (muscle pain)
  3. Oedema peripheral (superficial swelling)
  4. Sinusitis (inflammation of sinus)
  5. Stomatitis (inflammation of mucous membrane of mouth)
  6. Upper respiratory tract infection
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  8. Urinary tract infection
  9. Influenza like illness
  10. Escherichia infection (bacterial infection by escherichia coli)

male:

  1. Dysuria (painful or difficult urination)
  2. Nausea (feeling of having an urge to vomit)
  3. Aspartate aminotransferase increased
  4. Chest pain
  5. Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea (difficult or laboured respiration)
  8. Gingival bleeding (bleeding gums)
  9. Neck pain
  10. Oropharyngeal pain

What are the common drug interactions of Decitabine and Piperacillin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Constipation
  2. Cough
  3. Decreased appetite
  4. Diarrhoea
  5. Epigastric discomfort
  6. Gingivitis (inflammation of gums)
  7. Hypertension (high blood pressure)
  8. Hypokalaemia (low potassium)
  9. Hypotension (abnormally low blood pressure)
  10. Oral discomfort (pain or irritation in mouth)

60+:

  1. Thrombocytopenia (decrease of platelets in blood)
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Constipation
  4. Dizziness
  5. Generalised oedema (swelling all over the body)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Abdominal distension
  8. Anaemia (lack of blood)
  9. Chest pain
  10. Dacryostenosis acquired (obstruction of the nasolacrimal duct-acquired)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 19.05%
  2. Febrile Neutropenia (fever with reduced white blood cells): 3 people, 14.29%
  3. High Blood Pressure: 3 people, 14.29%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 9.52%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 9.52%
  6. Cellulitis (infection under the skin): 2 people, 9.52%
  7. Chest Pain: 2 people, 9.52%
  8. Computerised Tomogram Abdomen: 2 people, 9.52%
  9. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 9.52%
  10. Diarrhea: 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Decitabine and Piperacillin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Decitabine and Piperacillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Decitabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Piperacillin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Decitabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Piperacillin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on decitabine and piperacillin sodium (the active ingredients of Decitabine and Piperacillin, respectively), and Decitabine and Piperacillin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: